Organo-Se BTSAs-enabled performance: From racemic and asymmetric synthesis to click chemistry application
Zhi Zhou(Target (United States)), Wei Yi(Minzu University of China), Huiying Xu, Yuang Gu(ShanghaiTech University), Liexin Wu(State Key Laboratory of Respiratory Disease), Guang Yang(Imperial College London), Xi‐Yong Yu(State Key Laboratory of Respiratory Disease), Wei Zhang(Soochow University), Zhaoyong Zhang(Guangzhou Experimental Station), Wei Peng(Changsha University), Lei Ma(Guangzhou Experimental Station), Yan Wang(National Institute of Biological Sciences, Beijing), Jincun Zhao(ShanghaiTech University)
Cited by 37
Related Papers
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|724
Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections
|Cell Reports|2020|450
Rhodium(III)‐Catalyzed Redox‐Neutral Coupling of <i>N</i>‐Phenoxyacetamides and Alkynes with Tunable Selectivity
|Angewandte Chemie International Edition|2013|316
An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques
|Nature Communications|2020|247